To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
Clinical trial NCT03220217 · COMPLETED
Trial details
- NCT number
- NCT03220217
- Sponsor
- Ipsen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-26
- Primary completion
- 2019-07-25
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.